Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Non-Current Debt (2010 - 2026)

Updated

Northwest Biotherapeutics' Non-Current Debt was $12.24 million in Q2 2026, up 33.5% from $9.17 million a year earlier and up 69.9% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Non-Current Debt (2010 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Debt at Northwest Biotherapeutics came in at $12.33 million, down 0.5% from FY2024.

  • Non-Current Debt shows a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
  • In earlier years, Non-Current Debt was $12.4 million in FY2024 (-39.0%), $20.31 million in FY2023 (+239.0%), $5.99 million in FY2022 (-76.2%) and $25.16 million in FY2021 (+195.7%).
  • Quarterly Non-Current Debt has moved between $5.94 million (Q3 2022) and $25.16 million (Q4 2021) over five years.
  • Compared with a year earlier, Non-Current Debt was higher in three of the last eight quarters, with an average decline of 8.5%.
  • The best year-over-year quarter for Non-Current Debt over five years was Q4 2023 (growth of 239.0%); the worst was Q4 2022 (a decline of 76.2%).
  • Per Business Quant data, NWBO's Non-Current Debt in the three quarters before Q2 2026 was $7.2 million (Q1 2026), $12.33 million (Q4 2025) and $7.19 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 12.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.24 Mn
Mar 31, 2026 7.20 Mn
Dec 31, 2025 12.33 Mn
Sep 30, 2025 7.19 Mn
Jun 30, 2025 9.17 Mn
Mar 31, 2025 7.07 Mn
Dec 31, 2024 12.40 Mn
Sep 30, 2024 20.70 Mn
Jun 30, 2024 20.43 Mn
Mar 31, 2024 10.22 Mn
Dec 31, 2023 20.31 Mn
Sep 30, 2023 11.04 Mn
Jun 30, 2023 15.74 Mn
Mar 31, 2023 16.02 Mn
Dec 31, 2022 5.99 Mn
Sep 30, 2022 5.94 Mn
Jun 30, 2022 16.46 Mn
Mar 31, 2022 16.16 Mn
Dec 31, 2021 25.16 Mn
Sep 30, 2021 12.34 Mn
API Access

Northwest Biotherapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=NWBO&period=max&api_key=YOUR_API_KEY